Derivation of human embryonic stem cells in defined conditions
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
We have previously reported that high concentrations of basic fibroblast growth factor (bFGF) support feeder-independent growth of human embryonic stem (ES) cells, but those conditions included poorly defined serum and matrix components. Here we report feeder-independent human ES cell culture that includes protein components solely derived from recombinant sources or purified from human material. We describe the derivation of two new human ES cell lines in these defined culture conditions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Since the discovery of iPSC generation, the field has transitioned from using PSC culture media containing animal reagents to Xeno-free and even animal-free media [64,65,66].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [66]
Citations
Cites
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Self-citationYing, Q.-L., Nichols, J., Chambers, I., & Smith, A. (2003) · Cell · doi:10.1016/s0092-8674(03)00847-x · Cited by 2,122
Sato, N., Meijer, L., Skaltsounis, L., Greengard, P., & Brivanlou, A. H. (2004) · Nature Medicine · doi:10.1038/nm979 · Cited by 2,109
Amit, M., Carpenter, M. K., Inokuma, M. S., Chiu, C.-P., Harris, C. P., Waknitz, M. A., Itskovitz-Eldor, J., & Thomson, J. A. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9912 · Cited by 1,472
Self-citationBMP4 initiates human embryonic stem cell differentiation to trophoblast
Xu, R.-H., Chen, X., Li, D. S., Li, R., Addicks, G. C., Glennon, C., Zwaka, T. P., & Thomson, J. A. (2002) · Nature Biotechnology · doi:10.1038/nbt761 · Cited by 1,128
Self-citationRecurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells
Draper, J. S., Smith, K., Gokhale, P., Moore, H. D., Maltby, E., Johnson, J., Meisner, L., Zwaka, T. P., Thomson, J. A., & Andrews, P. W. (2004) · Nature Biotechnology · doi:10.1038/nbt922 · Cited by 1,021
Self-citationBasic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells
Xu, R.-H., Peck, R. M., Li, D. S., Feng, X., Ludwig, T., & Thomson, J. A. (2005) · Nature Methods · doi:10.1038/nmeth744 · Cited by 973
Self-citationHuman embryonic stem cells express an immunogenic nonhuman sialic acid
Martin, M. J., Muotri, A., Gage, F., & Varki, A. (2005) · Nature Medicine · doi:10.1038/nm1181 · Cited by 932
Feeder Layer- and Serum-Free Culture of Human Embryonic Stem Cells1
Amit, M., Shariki, C., Margulets, V., & Itskovitz-Eldor, J. (2004) · Biology of Reproduction · doi:10.1095/biolreprod.103.021147 · Cited by 664
Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors
Sperger, J. M., Chen, X., Draper, J. S., Antosiewicz, J. E., Chon, C. H., Jones, S. B., Brooks, J. D., Andrews, P. W., Brown, P. O., & Thomson, J. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235735100 · Cited by 648
Self-citation
Cited by
Items 801–900 of 1,000
A New Feeder-Free Technique to Expand Human Embryonic Stem Cells and Induced Pluripotent Stem Cells
Denham, M., Leung, J., Tay, C. Y., Wong, R. C. B., Donovan, P. J., Dottori, M., & Pébay, A. (2009) · The Open Stem Cell Journal · doi:10.2174/1876893800901010076 · Cited by 4
“[10] Ludwig TE, Levenstein ME, Jones JM, et al.”
BackgroundNeubauer, J. C., Bur, S., Meiser, I., Kurtz, A., & Zimmermann, H. (2019) · Veröffentlichungen des Instituts für Deutsches, Europäisches und Internationales Medizinrecht, Gesundheitsrecht und Bioethik der Universitäten Heidelberg und Mannheim · doi:10.1007/978-3-662-59052-2_2 · Cited by 4
Ávila‐González, D., Portillo, W., Barragán-Álvarez, C. P., Hernández‐Montes, G., Flores-Garza, E., Molina‐Hernández, A., Diaz-Martinez, N. E., & Díaz, N. F. (2022) · eLife · doi:10.7554/elife.68035 · Cited by 4
“FGF2 is the main factor required to maintain undifferentiated hESC (Eiselleova et al., 2009; Ludwig et al., 2006; MossahebiMohammadi et al., 2020).”
BackgroundChoi, K., Lee, D., Jeong, J., Ahn, Y., Go, D., Kim, D.-Y., & Lee, C. (2024) · Theriogenology · doi:10.1016/j.theriogenology.2024.05.027 · Cited by 4
αVβ5 and CD44 Are Oxygen-Regulated Human Embryonic Stem Cell Attachment Factors
Kumar, D., Gupta, S., Yang, Y., & Forsyth, N. R. (2013) · BioMed Research International · doi:10.1155/2013/729281 · Cited by 4
“Alternatives include collagen IV, fibronectin, laminin, vitronectin [9], recombinant vitronectin [8], human serum containing medium conditioned by human embryonic fibroblasts derived from hESCs [10], and hyaluronic acid hydrogels [11].”
Arabadjiev, A., Petkova, R., Chakarov, S., Pankov, R. G., & Zhelev, N. (2014) · Biodiscovery · doi:10.7750/biodiscovery.2014.14.2 · Cited by 4
“is substituted with cloned bFGF from zebrafish [96, 97].”
BackgroundDerivation of Human Embryonic Stem Cells
Crook, J. M., Kravets, L., Peura, T. T., & Firpo, M. T. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6921-0_8 · Cited by 4
Lewis, P. A., Silajdžić, E., Brison, D. R., & Kimber, S. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-37076-7_19-1 · Cited by 5
Robust protocol for feeder-free adaptation of cryopreserved human pluripotent stem cells
Aalders, J. G., den Vreken, N. V., Popovic, M., Mishra, S., Heindryckx, B., & van Hengel, J. (2019) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-019-00413-9 · Cited by 4
“Adapting hPSCs from feeder to feeder-free culture conditions on matrices such as Geltrex may impair cell viability or induce chromosomal abnormalities (Brimble et al. 2004; Ludwig et al. 2006).”
BackgroundCulturing pluripotent stem cells: State of the art, challenges and future opportunities
Regina, A. L., Pedone, E., & Marucci, L. (2021) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2021.100364 · Cited by 4
Goldberg-Cohen, I., Beck, G., Ziskind, A., & Itskovitz‐Eldor, J. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)18015-5 · Cited by 4
A Non‐Destructive Electrical Assay of Stem Cell Differentiation Based on Semiconductor Biosensing
Hideshima, S., Hayashi, H., Saito, S., Tateno, H., Momma, T., & Ōsaka, T. (2022) · Analysis & Sensing · doi:10.1002/anse.202200046 · Cited by 4
Canine induced pluripotent stem cells can be successfully maintained in weekend-free culture systems
Kimura, K., NAGAKURA, H., Tsukamoto, M., YOSHIDA, T., Sugisaki, H., Shishida, K., TACHI, Y., SHIMASAKI, S., Sugiura, K., & Hatoya, S. (2024) · Journal of Veterinary Medical Science · doi:10.1292/jvms.23-0422 · Cited by 4
“The mTeSR™ Plus medium (STEMCELL Technologies, Vancouver, BC, Canada) was developed based on the TeSR medium, which is the first reported medium for hPSC feeder-free culture [ 27, 28].”
Whye, D., Norabuena, E. M., Srinivasan, G. R., Wood, D., Polanco, T. J., Makhortova, N. R., Şahin, M., & Buttermore, E. D. (2024) · Current Protocols · doi:10.1002/cpz1.70022 · Cited by 4
“Two of the most widely used feeder-free hPSC growth media are the mTeSR1 and Essential 8 (E8) systems (Chen et al., 2011; Ludwig et al., 2006), and these media were uniquely designed to support the maintenance of hPSCs without the need for MEFs.”
Brain-CAVE Interface Based on Steady-State Visual Evoked Potential
Touyama, H. (2008) · InTech eBooks · doi:10.5772/5915 · Cited by 6
Recombinant Matrix Protein for Maintenance of Undifferentiated Primate Embryonic Stem Cells
Sato, H., Suemori, H., Toguchida, J., & Iwata, H. (2007) · Tissue Engineering · doi:10.1089/ten.2006.0383 · Cited by 4
Sousa, P. A. D. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.6.551 · Cited by 4
Current status of human embryonic stem cell research
Reubinoff, B. E. (2007) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60744-4 · Cited by 5
Chayosumrit, M. (2011) · The Open Stem Cell Journal · doi:10.2174/1876893801103010011 · Cited by 4
Koltsova, A. M., Voronkina, I. V., Гордеева, О. Ф., Zenin, V. V., Лифанцева, Н. В., Мусорина, А. С., Smagina, L. V., Jakovleva, T. K., & Poljanskaya, G. G. (2013) · Cell and Tissue Biology · doi:10.1134/s1990519x13010094 · Cited by 4
Derivation of Embryonic Stem Cells from Human Blastocysts
Rajan, P., Loring, J. F., Smotrich, D. B., Ross, R., & Laurent, L. C. (2007) · Elsevier eBooks · doi:10.1016/b978-012370465-8/50026-0 · Cited by 4
Klinefelter syndrome: A neurodevelopmental disease of the synapse
Zhao, H. W., Zhou, D., Feng, Y., & Haddad, G. G. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107010 · Cited by 3
“WA16 (KS) was obtained from WiCell and derived from a blastocyst (Ludwig et al., 2006).”
Arrieta-Viana, L. F., Méndez, J., & Torres‐Lugo, M. (2025) · RSC Advances · doi:10.1039/d5ra04674b · Cited by 3
“Cells were cultured on Cultrex basement membrane extracts (Cultrex ™ ) (R&D Systems, Minneapolis, USA) — a de ned ECM substitute derived from EHS mouse sarcoma and used as an alternative to Matrigel ™ 21 — coated 6-well plates using mTeSR-1 (StemCell Technologies, Vancouver, Canada) medium under feeder-free conditio…”
Human Embryonic Stem Cell Culture on BD Matrigel™ with mTeSR®1 Medium
Shi, M., Stencel, K., & Borowski, M. (2010) · Wiley eBooks · doi:10.1002/9780470889909.ch11 · Cited by 3
Vestentoft, P. S., Brøchner, C. B., Lynnerup, N., Andersen, C. Y., & Møllgård, K. (2014) · Methods in molecular biology · doi:10.1007/7651_2014_128 · Cited by 3
Culture, Adaptation, and Expansion of Pluripotent Stem Cells
Brehm, J. L., & Ludwig, T. E. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6921-0_10 · Cited by 3
Self-citationAmniogenesis in embryos and stem cell models
Tam, T. T. K. K., Xu, S., Li, Y., Wang, X., Chen, Y., Guo, J., Feng, Z., Lan, G., Ruan, D., Han, D., et al. (2026) · Nature Cell Biology · doi:10.1038/s41556-026-01873-4 · Cited by 3
Self-Renewal, Pluripotency and Tumorigenesis in Pluripotent Stem Cells Revisited
Li, Y., & Tetsuya, S. (2011) · InTech eBooks · doi:10.5772/15196 · Cited by 3
“Furthermore, animal products cannot be used to maintain human iPSCs for transplantation purposes (Ludwig et al., 2006b).”
BackgroundMethodInfluentialMedia and Extra Cellular Matrix Requirements for Large‐Scale ESC Growth
Robins, A. J., & Schulz, T. C. (2009) · Wiley eBooks · doi:10.1002/9780470454923.ch13 · Cited by 3
Nanotechnology in regenerative medicine
Yamato, M. (2006) · Drug Delivery System · doi:10.2745/dds.21.623 · Cited by 3
Human embryonic stem cells create their own niche
Jin, Y. (2007) · Cell Research · doi:10.1038/cr.2007.76 · Cited by 3
Feeder-Free Growth of Undifferentiated Human Embryonic Stem Cells
Hwang, D. (2011) · Springer protocols handbooks/Springer protocols · doi:10.1007/978-1-61779-267-0_1 · Cited by 3
Young, H. Y., Schulz, T., & Carpenter, M. K. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374729-7.00044-5 · Cited by 3
Biomechanics in Stem Cell Manufacturing
Janaszak, M. M., Wolfe, R. P., & Ahsan, T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-444-63265-4.00002-9 · Cited by 6
5.8 Scaffold Materials for Human Embryonic Stem Cell Culture and Differentiation ☆
Schaffer, D. V., & Willerth, S. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803581-8.10111-0 · Cited by 3
Chen, V. C., Couture, L. A., & Gold, J. (2017) · Cardiac and vascular biology · doi:10.1007/978-3-319-56106-6_7 · Cited by 4
Modern Ways of Obtaining Stem Cells
Çağlayan, Ş., Ahrens, T. D., Cieślar‐Pobuda, A., & Staerk, J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812258-7.00003-4 · Cited by 3
Preparation of Mouse Embryonic Fibroblasts as Feeders for iPSC Generation and Maintenance
Brehm, J. L., Miles, M. M., Remondini, K. S., & Ludwig, T. E. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-1084-8_14 · Cited by 3
Self-citationEmerging strategies for scalable human induced pluripotent stem cell expansion and differentiation
Nogueira, D. E. S., Rodrigues, C. A. V., & Cabral, J. M. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85766-6.00014-0 · Cited by 4
Ceschin, I. I., Ceschin, A. P., Joya, M. S., Mitsugi, T., Nishikawa, L. K. S., Krepischi, A. C. V., & Okamoto, O. K. (2022) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2022.11.020 · Cited by 3
Alsobaie, S. F., Alsobaie, T., Alshammary, A. F., Abudawood, M., & Mantalaris, A. (2023) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s409139 · Cited by 4
“Moreover, the combination of collagen IV, fibronectin, laminin, and vitronectin has been used to replace MatrigelTM to derive and expand human PSCs under defined culture conditions.(42) The ECM can also help the development of certain lineages, such as fibronectin and laminin, which stimulate neural cell lineage, and…”
MethodEmbryonic Stem Cells: A New Avenue to Evaluate the Effects of Chemicals in Humans
Cezar, G. G. (2006) · International Journal of Pharmaceutical Medicine · doi:10.2165/00124363-200620020-00004 · Cited by 4
“[72,73] In the absence of validation of these methods for isolation of hES, derivation of new hES lines in the US has been supported by patient consent and surplus fertilised eggs from in vitro fertilisation.[71]”
Nag, K., Adnan, N., Kutsuzawa, K., & Akaike, T. (2014) · InTech eBooks · doi:10.5772/58287 · Cited by 3
Hovatta, O. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0268-6 · Cited by 3
“Feederfree culture of existing hESC and hiPSC is feasible, but safe derivation of new lines has been challenging, with two feeder-free hECS lines being chromosomally abnormal [17].”
Cardiomyocytes from embryonic stem cells: towards human therapy
Földes, G., Harding, S. E., & Ali, N. N. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.10.1473 · Cited by 8
“Xenogenic issues are being promisingly addressed by Ludwig and colleagues who have developed a system for culturing hESC that is feeder-free and uses a medium that contains human-based components [118].”
BackgroundMemon, S., Lech, M., Maddage, N. C., & He, L. S. (2009) · InTech eBooks · doi:10.5772/7437 · Cited by 3
Pluripotent Stem Cells: Sources and Characterization
Palecek, S. P. (2010) · Springer eBooks · doi:10.1007/978-3-642-02824-3_4 · Cited by 3
“This system is also suitable for derivation of xeno-free hES cells [43].”
BackgroundSources and Derivation of Human Embryonic Stem Cells
Amit, M. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-348-0_1 · Cited by 3
New developments in stem-cell research
Simón, C., Pellicer, A., & Pera, R. A. R. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139540742.015 · Cited by 3
Embryonic and Pluripotent Stem Cells
Shouman, S., Hussein, A. E., Essawy, M., Abdelfattah‐Hassan, A., & El‐Badri, N. (2020) · Learning materials in biosciences · doi:10.1007/978-3-030-55359-3_2 · Cited by 3
Shen, J., Ly, K., & Hoang, Y. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385473-5.00005-9 · Cited by 7
Construction of Human Embryonic Stem Cell Banks: Prospects for Tissue Matching
Lin, G., Ou-Yang, Q., Qian, X., & Lu, G. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5480-9_7 · Cited by 4
“[76, 77] and StemPro hES cell SFM [78] are two commercially available chemically-defined media which have the capacity to maintain long-term and stable expansion of hES cells.”
BackgroundBiomanufacturing Human Pluripotent Stem Cells for Therapeutic Applications
Lian, X. L., & Palecek, S. P. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-940-2_3 · Cited by 3
Trends in biotech literature 2007
Taroncher‐Oldenburg, G., & Marshall, A. (2008) · Nature Biotechnology · doi:10.1038/nbt1008-1062 · Cited by 3
Development of a Xeno-Free Substrate for Human Embryonic Stem Cell Growth
Zhu, H., Yang, J., Wei, Y., & Chen, H. H. (2015) · Stem Cells International · doi:10.1155/2015/621057 · Cited by 2
“hESCs were cultured on methanol fixed xenofree ECM plate with either mTeSR1 (STEMCELL) [16] or TeSR-E8 medium (STEMCELL) [17].”
MethodWu, Y., Wang, Y., Zhang, W., Yuan, L.-L., & Chen, Y. (2026) · Stem Cell Research & Therapy · doi:10.1186/s13287-026-05080-8 · Cited by 2
“This effect might be attributed to several key growth factors in mTeSR, including FGF2, TGF-β and LiCl (a Wnt signaling activator) [76].”
Methods for the Derivation of Human Embryonic Stem Cell Lines
Amit, M., & Itskovitz‐Eldor, J. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-548-0_1 · Cited by 2
The Curses and the Blesses of E-Cadherin
Akaike, T. (2014) · Human Genetics & Embryology · doi:10.4172/2161-0436.1000118 · Cited by 2
Upregulation of Adhesion Molecules Sustains Matrix-Free Growth of Human Embryonic Stem Cells
Bigdeli, N., de Peppo, G. M., Karlsson, C., Lennerås, M., Strehl, R., Hyllner, J., & Lindahl, A. H. (2018) · The Open Stem Cell Journal · doi:10.2174/1876893801805010014 · Cited by 2
“As an alternative to feeder cells, the ability of extracellular matrix (ECM) components to support hESC attachment and proliferation has been evaluated, such as Matrigel [12, 13], Geltrex [14], fibronectin, laminin, entactin, and vitronectin [7, 15, 16].”
BackgroundAhn, Y., Jeong, J., Choi, K., Lee, D., Lee, M., Lee, N., Kim, D.-Y., & Lee, C. (2023) · Stem Cells and Development · doi:10.1089/scd.2023.0171 · Cited by 2
Khandani, B., & Movahedin, M. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10662-7 · Cited by 2
Safety Issues Related to Pluripotent Stem Cell-Based Therapies: Tumour Risk
Hillenius, S., Montilla‐Rojo, J., Eleveld, T. F., Salvatori, D. C. F., & Looijenga, L. H. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-41943-0_18 · Cited by 2
Xiao, Y., Wang, Y., Zhang, M., Zhang, Y., Ju, Z., Wang, J., Zhang, Y., Yang, C., Wang, X., Jiang, Q., et al. (2024) · Theriogenology · doi:10.1016/j.theriogenology.2024.11.010 · Cited by 2
Feofanov, M. N., Daubner, G. M., Saltalamacchia, A., Köhler, K., Schulz, C., Henry, C. E., Ziegler, M. J., Benabderrahmane, M. B., Hiault, F. A. S., Decker, T.-M., et al. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102167 · Cited by 3
“The first important advancement towards a serum-free medium was the publication of TeSR medium in 2006, which required basal medium and 18 additional components to maintain stem cells [1,2].”
Dady, A., Davidson, L., Loyer, N., Rappich, S., Findlay, G. M., Sanders, T., Januschke, J., & Storey, K. G. (2025) · Development · doi:10.1242/dev.205082 · Cited by 2
Truszkowski, L., Bottini, S., Bianchi, S., Scrivano, M. G., Ramondo, G. F., Belluci, L., Bell, H., Becca, S., Snijders, K. E., Savoré, G., et al. (2025) · Open Research Europe · doi:10.12688/openreseurope.18245.2 · Cited by 2
Klasen, L., Mork, M., Nasehi, R., Krishnamurthy, V. T., Zeevaert, K., Babendreyer, A., Russo, J. D., Wagner, W., & Laporte, L. D. (2026) · Advanced Materials · doi:10.1002/adma.75116 · Cited by 4
Characteristics and specific features of new human embryonic stem cell lines
Krylova, T. A., Koltsova, A. M., Zenin, V. V., Гордеева, О. Ф., Мусорина, А. С., Goryachaya, T. S., Sa, S., Kamenetskaya, Y. K., Pinaev, G. P., & Poljanskaya, G. G. (2010) · Cell and Tissue Biology · doi:10.1134/s1990519x10010013 · Cited by 2
“It seems that the refusal of feeder cells and the use of a feederless device and growth medium without additions of animal origins (Liu et al., 2006; Lu et al., 2006; Ludwig et al., 2006) is a successful means of obtaining ESCs for future transplantology.”
BackgroundCell culture systems for stem cell research
Meade, K. A., Holley, R. J., & Merry, C. L. R. (2011) · Elsevier eBooks · doi:10.1533/9780857092915.3.372 · Cited by 2
Sarkar, P., & Balaji, M. (2011) · InTech eBooks · doi:10.5772/22787 · Cited by 2
“FGF2 is required for maintaining hESCs in a pluripotent state [24, 54-55].”
BackgroundEmbryonic Stem Cells as a Potential Cure for Diabetes
Bukys, M. A., & Jensen, J. N. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-366-4_10 · Cited by 2
Derivation and Characterization of Rabbit Embryonic Stem Cells: A Review
Gócza, E., & Bösze, Z. (2009) · Springer eBooks · doi:10.1007/978-90-481-2227-1_9 · Cited by 4
Stem cell maintenance in a different niche
Lim, J. M., Ahn, J. Y., & Lee, S. T. (2013) · Daehan saengsik uihak hoeji/Clinical and experimental reproductive medicine · doi:10.5653/cerm.2013.40.2.47 · Cited by 2
“TeSR1 using recombinant proteins and purified material from humans was also suggested as a culture sup plement for hESC culture [26].”
MethodSimplified Slow Freezing Program Established for Effective Banking of Embryonic Stem Cells
Kim, G. A., Lee, S. T., Lee, E., Choi, J. K., & Lim, J. M. (2009) · Asian-Australasian Journal of Animal Sciences · doi:10.5713/ajas.2009.80181 · Cited by 2
“Mitotically inactivated fibroblasts have been utilized for supporting growth of HeLa cells, mouse embryonal carcinoma cells and ESCs (Puck and Marcus, 1955), which secrete critical factors for cell maintenance (Ying et al., 2003; Ludwig et al., 2006).”
BackgroundDerivation, maintenance and cryostorage of human embryonic stem cells
Holm, F., Bergström, R., Ström, S., & Hovatta, O. (2008) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2010.04.001 · Cited by 2
Au fil de la littérature sur les cellules ES
Savatier, P. (2007) · médecine/sciences · doi:10.1051/medsci/2007234358 · Cited by 2
“Des travaux récents sont particulièrement prometteurs, l’un de l’équipe de Michael Snyder à l’Université de Yale (États-Unis) (milieu HESCO) [10], l’autre de l’équipe de Jamie Thomson (milieu mTeSR1) [6].”
BackgroundPotential applications of human embryonic stem cells.
Sinawat, S. (2007) · PubMed · Cited by 2
TP53 et RB collaborent dans le développement des rétinoblastomes humains
Ayrault, O., Zindy, F., & Roussel, M. F. (2007) · médecine/sciences · doi:10.1051/medsci/2007234356 · Cited by 2
Mournetas, V., Nunes, Q. M., Murray, P. A., Sanderson, C. M., & Fernig, D. G. (2014) · PeerJ · doi:10.7717/peerj.618 · Cited by 2
Induced Pluripotent Stem Cells for Clinical Use
Seki, T., & Fukuda, K. (2016) · InTech eBooks · doi:10.5772/62505 · Cited by 3
“For example, human ESCs were successfully maintained with Matrigel and chemically defined medium [23].”
MethodInhibition of the integrin signal constitutes a mouse iPS cell niche
Higuchi, S., Yoshina, S., & Mitani, S. (2016) · Development Growth & Differentiation · doi:10.1111/dgd.12302 · Cited by 2
Human Feeder Cells, Feeder-free, and Defined Culture Systems
Wesselschmidt, R. L., & Loring, J. F. (2007) · Elsevier eBooks · doi:10.1016/b978-012370465-8/50007-7 · Cited by 2
New Trends in Clinical Applications of Induced Pluripotent Stem Cells
Pham, P. V., Phan, N. L.-C., Vu, N. B., Truong, N. H., & Phan, N. K. (2016) · Stem cells in clinical applications · doi:10.1007/978-3-319-40073-0_4 · Cited by 2
Substrates and Surfaces for Control of Pluripotent Stem Cell Fate and Function
Srinivasan, A., Toh, Y., Loh, X. J., Loh, X. J., Loh, X. J., Toh, W. S., & Toh, W. S. (2016) · Wiley eBooks · doi:10.1002/9781119242642.ch12 · Cited by 2
Chemically Defined Neural Conversion of Human Pluripotent Stem Cells
Chen, Y., Tristan, C. A., Mallanna, S. K., Ormanoglu, P., Titus, S. A., Simeonov, A. M., & Singeç, I. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9007-8_5 · Cited by 2
Yu, J., & Thomson, J. A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385942-6.00022-6 · Cited by 2
Self-citationThe Molecular Circuitry Underlying Pluripotency in Embryonic Stem Cells and iPS Cells
Singh, H., & Brivanlou, A. H. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385942-6.00005-6 · Cited by 2
Lewis, P. A., Silajdžić, E., Brison, D. R., & Kimber, S. J. (2020) · Springer eBooks · doi:10.1007/978-3-319-08831-0_19 · Cited by 5
Snyder, E. Y., & Yip, S. S. F. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-3479-7.10007-2 · Cited by 2
LINE-1 Retrotransposition Assays in Embryonic Stem Cells
García-Cañadas, M., Sanchez-Luque, F. J., Sánchez, L., Rojas, J., & Garcia-Perez, J. L. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2883-6_13 · Cited by 2
Sphere-Based Expansion of Myogenic Progenitors from Human Pluripotent Stem Cells
Reilly, M. L., Robertson, S., & Suzuki, M. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3036-5_12 · Cited by 2
The Molecular Basis of Embryonic Stem Cell Self-Renewal
Dalton, S. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-227-8_1 · Cited by 2
“This clearly portrays a different picture from that which has emerged from studies in mESCs [63, 64].”
ResultPlews, J. R., & Wu, J. C. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-374984-0.00473-3 · Cited by 2
Nguyen, T. Y., Liew, C. G., & Liu, H. H. (2014) · PLoS ONE · doi:10.1371/annotation/53062b94-8b47-4bdd-bde6-2725cb0a02d9 · Cited by 2
Imamura, S., Wen, X., Terada, S., Yamamoto, A., Mutsuda-Zapater, K., Sawada, K., Yoshimoto, K., Tanaka, M., & Kamei, K. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.23.497328 · Cited by 3
Novotny, L. A., Kappler, C. S., & Meissner, E. G. (2025) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2024.0262 · Cited by 1
“Cells were plated on Matrigel-coated plates and cultured in mTeSR medium (Ludwig et al., 2006a; Ludwig et al., 2006b) supplemented with 40 ng/mL zebra fi sh bFGF and 1 m g/mL puromycin (Sigma-Aldrich) for 2 days to select for colonies that incorporated the plasmid.”
Zorzan, I., Carbognin, E., Lauria, A., Proserpio, V., Benvegnù, D., Bertelli, F., Urías, S. D. J., Dalrio, C., Panebianco, G., Scarfò, R., et al. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01831-6 · Cited by 1
“Therefore we used a chemically defined medium (E8) 45,46 , containing ligands of these three pathways: TGFB1, FGF2 and INSULIN.”
Lei, C., Wang, F., He, J., Sun, M., Wang, Y., Wang, Y., Wang, S.-H., An, L., Xi, G., & Tian, J. (2026) · Biology of Reproduction · doi:10.1093/biolre/ioag089 · Cited by 1
“It has been widely used for feeder-free culture of human pluripotent stem cells [ 30, 32, 34, 50, 51].”
Modeling myeloid cell development in health and disease using induced pluripotent stem cells
Tesakov, I., Nasri, M., Klimiankou, M., Fındık, B., Loskill, P., & Skokowa, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1815809 · Cited by 1
“To reduce xenogeneic components and facilitate further clinical translation, feeder-free systems have been developed using de fi ned extracellular matrices (for example vitronectin, laminin-521, Matrigel) and chemically de fi ned media such as mTeSR1, E8 or similar formulations (46 – 49).”
Microfluidic Image Cytometry for Single-Cell Phenotyping of Human Pluripotent Stem Cells
Mashimo, Y., & Kamei, K. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2987-0_7 · Cited by 1
Metadata
- Authors
- Ludwig, T. E., Levenstein, M. E., Jones, J. M., Berggren, W. T., Mitchen, E. R., Frane, J. L., Crandall, L. J., Daigh, C. A., Conard, K. R., Piekarczyk, M. S., Llanas, R. A., & Thomson, J. A.
- Affiliations
- WiCell (US)
- University of Wisconsin–Madison (US)
- Corresponding author
- Thomson, James A
- Venue
- Nature Biotechnology
- Published
- 2006-01-01
- Volume
- 24
- Issue
- 2
- Pages
- 185-187
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2038723730
- Cited by
- 1,114
- References
- 15
- Citations by year
- 2026: 15 · 2025: 19 · 2024: 20 · 2023: 25 · 2022: 26 · 2021: 28 · 2020: 31 · 2019: 31 · 2018: 34 · 2017: 48 · 2016: 39 · 2015: 55 · 2014: 65 · 2013: 80 · 2012: 85
- FWCI
- 43.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r24rr017721-04)
- U.S. Public Health Service (P20-GMO69981)
- National Center for Research Resources (R24-RR017721)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- human embryonic stem cells, defined culture conditions, basic fibroblast growth factor, recombinant growth factors, stem cell derivation, stem cell lines, serum-free culture
- MeSH terms
- Cell Differentiation, Cell Line, Cell Survival, Culture Media, Humans, Stem Cells, Cell Culture Techniques, Tissue Engineering, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.